{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:48:54Z","timestamp":1764240534914,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.yebeh.2022.108744","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T02:11:26Z","timestamp":1652753486000},"page":"108744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["COVID-19 vaccination for patients with benign childhood epilepsy with centrotemporal spikes"],"prefix":"10.1016","volume":"134","author":[{"given":"Xinyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.108744_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102434","article-title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China","volume":"109","author":"Yang","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.yebeh.2022.108744_b0010","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.vaccine.2010.04.021","article-title":"Use of the Australian Childhood Immunisation Register for vaccine safety data linkage","volume":"28","author":"Gold","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.yebeh.2022.108744_b0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jama.2020.26553","article-title":"Mandating COVID-19 vaccines","volume":"325","author":"Gostin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2022.108744_b0020","unstructured":"COVID19 Vaccine Tracker. COVID. https:\/\/covid19.trackvaccines.org\/; 2022 [accessed March 9 2022]."},{"issue":"1","key":"10.1016\/j.yebeh.2022.108744_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1949950","article-title":"COVID-19 vaccination in Chinese children: a cross-sectional study on the cognition, psychological anxiety state and the willingness toward vaccination","volume":"18","author":"Yang","year":"2022","journal-title":"Human Vacc Immunother"},{"key":"10.1016\/j.yebeh.2022.108744_b0030","unstructured":"China. COVID. https:\/\/covid19.trackvaccines.org\/country\/china\/; 2021 [accessed December 13 2021]."},{"key":"10.1016\/j.yebeh.2022.108744_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/epi.12306","article-title":"Epilepsy and vaccinations: Italian guidelines","volume":"54","author":"Pruna","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108744_b0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.seizure.2021.08.001","article-title":"Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study","volume":"92","author":"Massoud","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108744_b0045","article-title":"COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center","volume":"122","author":"Wrede","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108744_b0050","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S1473-3099(21)00384-4","article-title":"COVID-19 vaccines for children younger than 12 years: are we ready?","volume":"21","author":"Zou","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108744_b0055","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1528-1167.2011.03134.x","article-title":"A retrospective population-based study on seizures related to childhood vaccination","volume":"52","author":"von Spiczak","year":"2011","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.yebeh.2022.108744_b0060","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.vaccine.2021.03.009","article-title":"Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study","volume":"39","author":"Righolt","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.yebeh.2022.108744_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-018-1112-0","article-title":"Risk of seizures after immunization in children with epilepsy: A risk interval analysis","volume":"18","author":"Top","year":"2018","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.yebeh.2022.108744_b0070","doi-asserted-by":"crossref","unstructured":"Guerrini R, Pellacani S, Benign childhood focal epilepsies. Epilepsia, 2012;53,9\u201318. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03609.","DOI":"10.1111\/j.1528-1167.2012.03609.x"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108744_b0075","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ejpn.2017.02.002","article-title":"Coexistence of childhood absence epilepsy and benign epilepsy with centrotemporal spikes: A case series","volume":"21","author":"Verrotti","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108744_b0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.410370205","article-title":"Outcome assessment for epilepsy surgery: The impact of measuring health-related quality of life","volume":"37","author":"Vickrey","year":"1995","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2022.108744_b0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-COV-2 infection after vaccination in users of the COVID symptom study app in the UK: A prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.yebeh.2022.108744_b0090","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4161\/hv.21408","article-title":"Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA toxicity grading scale guidance","volume":"8","author":"Norquist","year":"2012","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.yebeh.2022.108744_b0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0887-6185(92)90026-4","article-title":"Reliability and validity of the Beck Anxiety Inventory","volume":"6","author":"Fydrich","year":"1992","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.yebeh.2022.108744_b0100","doi-asserted-by":"crossref","unstructured":"Ariamanesh M, Porouhan P, PeyroShabany B, Fazilat-Panah D, Dehghani M, Nabavifard M, et al. Immunogenicity and safety of the inactivated SARS-COV-2 vaccine (BBIBP-CorV) in patients with malignancy. Cancer Invest 2021. https:\/\/doi.org\/10.1101\/2021.09.02.21262760.","DOI":"10.1101\/2021.09.02.21262760"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108744_b0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","article-title":"Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: A randomised, double-blind, controlled, phase 1\/2 trial","volume":"22","author":"Xia","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.yebeh.2022.108744_b0110","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/vaccines9090999","article-title":"IGG antibodies generation and side effects caused by ad5-ncov vaccine (Cansino Biologics) and BNT162B2 vaccine (Pfizer\/BioNTech) among Mexican population","volume":"9","author":"Guzm\u00e1n-Mart\u00ednez","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.yebeh.2022.108744_b0115","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.yebeh.2022.108744_b0120","article-title":"Self-reported safety of the BBIBP-corv (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis","author":"Etemadifar","year":"2021","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.yebeh.2022.108744_b0125","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1080\/21645515.2020.1834325","article-title":"Factors associated with parents\u2019 willingness to enroll their children in trials for covid-19 vaccination","volume":"17","author":"Goldman","year":"2021","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.yebeh.2022.108744_b0130","first-page":"1","article-title":"Covid-19 vaccine hesitancy among patients with epilepsy or other chronic conditions","author":"Asadi-Pooya","year":"2021","journal-title":"Disaster Med Public"},{"key":"10.1016\/j.yebeh.2022.108744_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107340","article-title":"Evaluation of anxiety, depression, and sleep quality among parents of children with epilepsy in southern China","volume":"112","author":"Yang","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108744_b0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/INF.0000000000002553","article-title":"Adverse events following immunization among children with epilepsy","volume":"39","author":"Top","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.yebeh.2022.108744_b0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1212\/WNL.0000000000001855","article-title":"Effect of vaccinations on seizure risk and disease course in Dravet syndrome","volume":"85","author":"Verbeek","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108744_b0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1528-1167.2010.02885.x","article-title":"A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome","volume":"52","author":"Tro-Baumann","year":"2011","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022001937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022001937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:48:03Z","timestamp":1761504483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022001937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"alternative-id":["S1525505022001937"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108744","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccination for patients with benign childhood epilepsy with centrotemporal spikes","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108744"}}